Three notable orthopedic deals took place between Oct. 15 and Nov. 15, the largest being the acquisition of Wright Medical by Stryker. The $5.4 billion deal is expected to close in the second half ...
More than 4 thousand doctors attended the sixth annual meeting of the American Association of Hip and Knee Surgeons from Nov. 7-10 at the Hilton Anatole in Dallas, Texas. AAHKS President Michael P ...
Orthopedic industry revenue increased 4.5 percent in Q3-2019 when compared with Q3-2018. All segments exhibited single-digit growth except neuromodulation. Compared with the same quarter last year,...
Glaukos, maker of the iStent inject, announced Nov. 21 that it has completed its previously announced acquisition of Avedro, developer of corneal cross-linking. Thomas Burns, Glaukos president and ...
Roche once again delayed its tender offer for the $4.3 billion acquisition of Spark Therapeutics. “[T]o provide additional time for the US Federal Trade Commission (FTC) and the UK Competition and ...
Eye injuries from nonpowder firearm incidents are on the rise in the United States, according to a new study by researchers at the Center for Injury Research and Policy at Nationwide Children’s Hos...
Biogen, of Cambridge, Massachusetts, announced Nov. 21 that it had enrolled the last patient in its global Phase III STAR clinical study, evaluating the investigational gene therapy timrepigene emp...
Nidek announced Nov. 18 that the US FDA had issued 510(k) clearance for the YC-200 ophthalmic YAG laser system. The YC-200 also comes in the S plus model for selective laser trabeculoplasty (SLT). ...
LightMed, of San Clemente, California, announced the launch on Nov. 18 of its LIGHTLas TruScan Pro V2.0, an advanced and flexible pattern-scanning laser that can be configured with up to four diffe...
Nuvectra announced Nov. 14 that it filed for reorganization under Chapter 11 of the US Bankruptcy Code. It also filed for consensual collateral support and employee wage and benefit support from th...
Global revenue for ophthalmic lasers—photocoagulation, photodisruption (YAG), and SLT—along with maintenance, accessories, and endoprobes, will total nearly $406 million in 2019 and grow at a compo...
Currently, 11 artificial disc replacement (ADR) devices are approved by the FDA. The first ADRs were for lumbar cases. However, insurance companies in the US stopped covering the procedure in 2013 ...
The American Academy of Ophthalmology’s Retina Subspecialty Day cast a big net with its 2019 agenda, covering surgical and medical retina and diagnostics. The two-day program preceded the AAO’s ann...
Keratoconus and ectasia were frequent topics in conference sessions and during the Refractive and Cornea Subspecialty Days at the 2019 AAO meeting. Physicians were eager to gain a better understand...
Ophthalmic deals garnered over $9 billion from January 2018 through October 2019, driven largely by dry eye and retina related fundraising. Over 100 transactions occurred during this period, and ov...
Aurinia Pharmaceuticals’ initiation of its Phase II/III AUDREY trial in dry eye keeps Aurinia in the middle of the pack of companies racing to develop the next pharmaceutical treatment for dry eye ...
Alcon reported Nov. 19 that its Q3-2019 sales totaled $1.84 billion, an increase of 4 percent (+6 percent cc) over $1.76 billion in Q3-2018. The Switzerland-registered, Texas-based company raised i...
The US Food and Drug Administration (FDA) approved on Nov. 15 the first contact lens indicated to slow the progression of myopia (nearsightedness) in children between the ages of 8 and 12 at the in...
Aerie Pharmaceuticals announced Nov. 21 that the European Commission (EC) had granted marketing authorization for Rhokiinsa—known as Rhopressa in the US—for the reduction of elevated intraocular pr...
The US Food and Drug Administration (FDA) has accepted for review Samsung Bioepis’ biologics license application (BLA) for SB8, a biosimilar candidate referencing Genentech’s Avastin (bevacizumab),...
Patients at CarePortMD retail health clinics at Albertsons grocery stores now have access to a diabetic retinopathy eye exam performed with the FDA-cleared autonomous AI diagnostic system IDx-DR. A...
Hong Kong’s Baring Private Equity Asia announced Nov. 19 that its affiliated funds have agreed to acquire Israel-based Lumenis, maker of ophthalmic lasers and other energy-based medical devices, fr...
French company Nicox has issued3,315,650 new ordinary shares through a private placement, with gross proceeds of $13.9 million, the company announced Nov. 18. Proceeds from the financing will suppo...
NovaBay Pharmaceuticals announced Nov. 18 that it had launched NovaSight, a proprietary daily vitamin and mineral supplement specially formulated to support ocular health, on Amazon.com. NovaSight ...
Career development company CovalentCareers has released its 2019 Optometrist Report, based on data collected from 1,181 optometrists, optometry students, and practice owners. The report details opt...
Aerie Pharmaceuticals, of Durham, North Carolina, has signed an agreement for the acquisition of Avizorex Pharma (AVX), a Spanish company developing therapeutics for the treatment of dry eye diseas...
Gene therapy company Regenxbio has filed a lawsuit against the US FDA and Health Secretary Alex Azar II over FDA regulators placing clinical holds on two of the company’s clinical trials for RGX-31...
Bausch Health and Clearside Biomedical have agreed on a deal to develop and commercialize Clearside’s Xipere (triamcinolone acetonide suprachoroidal injectable suspension) in the US and Canada, the...
Alcon’s PanOptix trifocal lens garnered much of the attention at refractive- and cataract-focused sessions and on the exhibit floor at the 2019 meeting of the American Academy of Ophthalmology, hel...
Private equity was a common theme at the 2019 AAO meeting, and discussions often centered on the increasing consolidation within ophthalmology. Sessions focused on educating ophthalmologists and pr...
Ellex and the International Ophthalmic Floater Society (IOFS) sponsored a symposium on advancements in technology that have improved the opportunities for floater treatment. The event was held in c...
A debate on 3D heads-up displays stood out during the Retina Subspecialty Day because the discussion differed greatly from the terms used to market the devices just three years ago. Jennifer Lim, M...
A record crowd attended the 2019 Ophthalmology Innovation Summit in advance of the AAO meeting. The meeting was held Oct. 10 at the Hilton San Francisco Union Square. Forty-one percent of the 1,150...
Amarantus Bioscience announced Oct. 24 that it agreed to license its therapeutic assets to Emerald Organic Growth, a cannabinoid-based health sciences company located in Holbrook, New York. It is u...
Oyster Point Pharma led recent fundraising efforts by ophthalmic companies, raising $92 million in gross proceeds in its initial public offering. Other firms with financing deals included Nicox, ra...
Johnson & Johnson Vision (J&J Vision) announced Oct. 28 that it will cease customer-facing operations for Sightbox, its online contact lens subscription service, while it evaluates options for the ...
Global revenue for ophthalmic lasers—photocoagulation, photodisruption (YAG), and SLT—along with maintenance, accessories, and endoprobes, will total nearly $406 million in 2019 and grow at a compo...
Spencer P. Thornton, MD, FACS, a renowned ophthalmologist and former president of the American Society of Cataract and Refractive Surgery (ASCRS), died Oct. 26 at the age of 90. Colleagues remember...
Coherus BioSciences will market and distribute Bioeq AG’s ranibizumab biosimilar candidate in the US under a licensing agreement announced Nov. 6. Bioeq, of Switzerland, will retain responsibility ...
Medacta and Geisinger announced in 2018 that they were launching a pilot program for lifetime-guaranteed hip replacements; the companies added knee replacements to the program in March 2019. On Nov...
Bioness, a California-based provider of the StimRouter Peripheral Nerve System (PNS), announced Nov. 14 that positive clinical trial results for the device were published in the November issue of P...
Announced Nov. 5, the US Centers for Medicare and Medicaid Services increased the Medicare physician payment for sacroiliac (SI) joint arthrodesis. Starting Jan. 1, the relative value units for the...
Spineology announced Nov. 4 that 24-month outcomes for its SCOUT clinical trial are positive. The trial is prospective, multi-center, and non-randomized, and it follows IDE protocol. One hundred an...
Gene therapy company Regenxbio has filed a lawsuit against the US FDA and Health Secretary Alex Azar II over FDA regulators placing clinical holds on two of the company’s clinical trials for RGX-31...
Omeros reported Nov. 12 that its Q3-2019 revenue was $29.9 million, a 12 percent increase over the previous quarter in 2019. Omidria is the company’s sole product for sale. Omeros has seen strong d...
NuEyes, of Newport Beach, California, announced Nov. 12 that the US Patent and Trademark Office had issued the company US Patent 10,429,675 for a “System for Using Augmented Reality for Vision.” Th...
Iridex reported Nov. 7 that Q3-2019 revenue totaled $10.7 million, a decrease of 5.8 percent from $11.3 million in the same period of 2018. Revenue from retinal products was $5.8 million, a decreas...
Harrow Health reported Nov. 13 that Q3-2019 revenue totaled $12.8 million, a 19 percent increase over Q3-2018 revenue of $10.7 million. Harrow, founded in 2014 and now located in Nashville, Tenness...
Coherus BioSciences will market and distribute Bioeq AG's Lucentis biosimilar candidate in the US under a licensing agreement announced Nov. 6. Bioeq, of Switzerland, will retain responsibility...
Bausch Health announced Nov. 4 that its Bausch + Lomb/International segment posted Q3-2019 revenue of $1.18 billion, a 2 percent increase (4 percent cc) over Q3-2018 revenue of $1.15 billion. The i...
Alimera Sciences has terminated its $20 million common stock purchase agreement with Lincoln Park Capital Fund, the company announced Nov. 12. Rick Eiswirth, president and CEO of Alimera, said: “Ha...
The Hospital for Special Surgery (HSS) announced Nov. 7 that it is enrolling patients in a study that uses 3dMD technology and EOS imaging to treat scoliosis patients. 3dMD’s imaging system reduces...
Flexion Therapeutics said Oct. 31 that the FDA has approved its Investigational New Drug (IND) application for gene therapy treatment FX201. The therapy is a non-integrating adenovirus containing t...
WishBone Medical announced Oct. 29 that it signed a global distribution agreement with Optimal for its pediatric orthopedic implant systems. Optimal is an automated logistics inventory service comp...
Life Spine settled the civil health care fraud lawsuit filed against it under the False Claims Act for $6 million, the company announced Oct. 25. The case, started in February 2018, centered around...
The GID Group, a cellular medicine company based in Colorado, is moving toward FDA market approval for its SVF-2 treatment for osteoarthritis. The latest clinical trial results were posted on Aug. ...
Perimetry devices are primarily used by eye care professionals as a tool to help diagnose and stage glaucoma patients. The glaucoma diagnostic market as a whole is worth $388 million; perimetry dev...
STAAR Surgical reported Oct. 30 that its net sales for Q3-2019 were $39.1 million, up 23 percent from Q3-2018. Net sales for its implantable collamer lens (ICL) increased 28 percent to $33.8 millio...
Regeneron’s US net sales of Eylea in Q3-2019 totaled $1.19 billion, a 16 percent increase over Q3-2018, the Tarrytown, New York, company announced Nov. 5. Bayer, which licenses Eylea outside the US...
LENSAR recorded Q3-2019 revenue of $8.1 million from its LENSAR Laser System, representing a 22 percent increase over Q3-2018, parent PDL BioPharma reported Nov. 6. PDL said the majority of the inc...
Glaukos’ net sales in Q3-2019 totaled $58.5 million, a 33 percent increase over net sales of $43.9 million in the third quarter of 2018, the San Clemente, California, company announced Nov. 6. Glau...
Avedro’s net sales grew to $11 million in Q3-2019, a 38 percent increase over Q3-2018 net sales of $8 million, the Waltham, Massachusetts, company announced Nov. 6. US revenue rose $3.6 million for...
Allergan reported Nov. 5 that its Q3-2019 net revenue totaled $4.05 billion, a 3.6 percent increase over Q3-2018. In the US, Restasis’ net revenue was $286.8 million, a decrease of 3.8 percent, whi...
Spencer P. Thornton, MD, FACS, a renowned ophthalmologist and former president of the American Society of Cataract and Refractive Surgery (ASCRS), died Oct. 26 at the age of 90. Colleagues remember...
President Donald Trump said Nov. 1 that he intended to nominate Stephen Hahn, MD, a top executive at the University of Texas MD Anderson Cancer Center, to be the next commissioner of the US FDA, ac...
Applied Genetic Technologies Corporation (AGTC), with facilities in Florida and Massachusetts, announced Nov. 5 that it had identified Stargardt disease as the second ophthalmology program in its p...
EyePoint Pharmaceuticals, of Watertown, Massachusetts, announced Nov. 4 that it had signed an interim agreement with the US Department of Veteran Affairs for Dexycu and Yutiq to be included on the ...
French company Pixium Vision announced Nov. 6 that it had concluded a financing agreement with a US-based health care investor, the European Select Growth Opportunities Fund, for the development of...
Q BioMed Inc., of New York, announced Nov. 5 that its technology partner, Mannin, had received a $7.5 million grant from the German state of Saxony. Mannin is a research-stage biotechnology company...
Samsung Bioepis, of Incheon, South Korea, announced Nov. 6 that Biogen had agreed to a commercial license for two biosimilar candidates under development by Samsung Bioepis—SB11 (ranibizumab) and S...
During the past month, 52 orthopedic medical devices have received FDA 510(k) clearance. Eighteen of the devices are spine implants. Eight of these are for spine fixation, including three plates an...
Results from two recent clinical studies demonstrated promising methods to stimulate regrowth of damaged cartilage tissue. If intraarticular cartilage can be regenerated, more osteoarthritis cases ...
Market Scope surveys spine, knee, hip, and shoulder surgeons every quarter about procedure volumes, preferred treatments, adoption of new technology, surgical techniques, and plans. Our Q3-2019 spi...
Between Sept. 20 and Oct. 20, five important orthopedic deals took place: one acquisition, one manufacturing agreement, one round of Series A financing, one equity announcement, and a grant. Not in...
Currently, 11 artificial disc replacement (ADR) devices are approved by the FDA. Only three of these are approved for use in the lumbar spine, and only two are currently marketed (ActivL and Prodis...
The 2019 EUROSPINE congress was held Oct. 16-18 at the Messukeskus Expo and Convention Centre in Helsinki, Finland. Over 2 thousand health care professionals attended, representing 83 countries. Me...
US orthopedic surgeons and neurosurgeons received a total of $2.7 billion in payments from drug and device manufacturers from 2014 through 2018, according to Market Scope’s analysis of the CMS Open...
Garwood Medical Devices, a medical equipment manufacturer in New York, issued a press release on Oct. 23, stating that its BioPrax device received breakthrough device designation from the FDA. BioP...
On Oct. 21., Smith & Nephew announced that its CEO, Namal Nawana, would leave his position by mutual agreement on Oct. 31. Roland Diggelmann assumed the role on Nov. 1, and Nawana will advise him u...
EOS imaging said Oct. 21 that its hipEOS 3.0 surgical planning software was paired with Intellijoint Surgical’s HIP navigation system at the Hospital for Special Surgery (HSS) in New York. hipEOS 3...
Canada-based Synaptic Medical announced Oct. 17 that it is entering the spine surgical market with its robotically controlled digital microscope, Modus V. The Modus V moves based on the position of...
Oyster Point Pharma raised $92 million in gross proceeds in its initial public offering Oct. 31. President and CEO Jeffrey Nau, PhD, and several Oyster Point employees rang the Nasdaq opening bell ...
Johnson & Johnson Vision (J&J Vision) announced Oct. 28 that it will cease customer-facing operations for Sightbox, its online contact lens subscription service, while it evaluates options for the ...
Amarantus Bioscience announced Oct. 24 that it agreed to license its therapeutic assets to Emerald Organic Growth, a cannabinoid-based health sciences company located in Holbrook, New York. It is u...
Alimera Sciences, of Alpharetta, Georgia, has entered into a common stock purchase agreement of up to $20 million with Lincoln Park Capital Fund LLC, a Chicago-based institutional investor, the com...
Luneau Technology, of France, announced Oct. 11 that it had acquired Next Sight, an Italian company specializing in retinal screening and telehealth. Terms of the deal were not disclosed. Luneau’s ...
Allergan announced Oct. 14 that its shareholders had voted to approve the previously announced proposed acquisition of Allergan by AbbVie. More than 99 percent of the votes cast at both a special c...
Avellino Labs announced Oct. 14 that the company had received Clinical Laboratory Improvement Amendments (CLIA) certification for its AvaGen product, the first genetic test for determining risk of ...
Wills Eye Hospital announced Oct. 23 that its ophthalmologist-in-chief, Julia A. Haller, MD, was elected to the US National Academy of Medicine (NAM). The honor is considered one of the highest in ...
Galimedix Therapeutics has appointed Alexander Gebauer, MD, PhD, as executive chairman of the board, the company announced Oct. 21. Gebauer succeeds founder Andrew Pearlman, PhD, who will remain on...
Notal Vision has appointed Kester Nahen, PhD, as chief executive officer, the company announced Oct. 23. Nahen joined the company as chief commercial officer in August. Prior to joining Notal Visio...
Spark Therapeutics, of Philadelphia, announced Oct. 25 that it had been awarded the prestigious 2019 Prix Galien USA Award for Best Biotechnology Product for its retinal gene therapy Luxturna. The ...
NovaBay Pharmaceuticals has entered into an exclusive 90-day agreement with NuSight Medical to distribute the NuLids System for treatment of blepharitis and dry eye in six of NovaBay’s top-performi...
TLC, of Taipei, Taiwan, said Oct. 24 that it had closed a cash capital offering of ordinary or common shares. The offering consisted of 10.2 million new common shares issued at a price of NT $82 (U...
LimaCorporate announced Oct. 15 that is signed a distribution agreement with Dedienne Santé for Dedienne’s dual-mobility acetabular cup portfolio, Symbol. Under the terms, LimaCorporate will distri...
Creative Medical Technology Holdings said Oct. 17 that StemSpine achieved clinical commercialization and will launch soon in the US. Creative Medical focuses on stem cell treatments for orthopedics...
CMR Surgical announced Oct. 16 that Galaxy Care Hospital in India became the first to acquire CMR’s Versius Surgical Robotic System. Galaxy Care Hospital is a large, well-known laparoscopic surgery...
Arthrosurface announced publication of its recent study results in the October issue of JESE Open Access. Thirty-one shoulder replacements in 29 patients were compared using the Penn Shoulder Score...
A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.